We are live on ! Find out more
NLVP

New Leaf Venture Partners Portfolio holdings

AUM $43M
1-Year Est. Return 25.55%
This Fund
S&P 500
This Quarter Est. Return
-16.34%
1 Year Est. Return
-25.55%
3 Year Est. Return
+17.13%
5 Year Est. Return
+114.46%
10 Year Est. Return
+1,011.57%
AUM
$77.9M
AUM Growth
-$38.6M
Cap. Flow
-$18.5M
Cap. Flow %
-23.71%
Top 10 Hldgs %
99.43%
Holding
14
New
–
Increased
–
Reduced
1
Closed
2
Avg Time Held
16.3 quarters
Top 10 Avg Time Held
8.1 quarters
Top 20 Avg Time Held
15 quarters

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
DICE icon
DICE Therapeutics, Inc. Common Stock
DICE
+$17.3M
2
ARAV
Aravive, Inc. Common Stock
ARAV
+$1.19M
3
HARP
Harpoon Therapeutics, Inc. Common Stock
HARP
+$15

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
ARVN icon
1
Arvinas
ARVN
$494M
$25.4M 32.6%
1,289,521
– –
2018 Q3
20 quarters
DCPH icon
2
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$15.4M 19.76%
1,209,571
– –
2017 Q3
24 quarters
RLYB icon
3
Rallybio
RLYB
$89.9M
$11.1M 14.29%
412,700
– –
2021 Q3
8 quarters
EWTX icon
4
Edgewise Therapeutics
EWTX
$4.21B
$8.9M 11.43%
1,553,661
– –
2021 Q1
10 quarters
COGT icon
5
Cogent Biosciences
COGT
$5.26B
$4.89M 6.28%
501,530
– –
2018 Q1
22 quarters
CRNX icon
6
DELISTED
Crinetics Pharmaceuticals
CRNX
$4.19M 5.38%
141,000
– –
2018 Q3
20 quarters
RCKT icon
7
Rocket Pharmaceuticals
RCKT
$272M
$2.42M 3.11%
118,242
– –
2022 Q4
3 quarters
ALEC icon
8
Alector
ALEC
$226M
$2.2M 2.83%
339,569
– –
2019 Q1
18 quarters
PASG icon
9
Passage Bio
PASG
$12.1M
$1.65M 2.12%
124,896
– –
2020 Q1
14 quarters
HARP
10
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$1.27M 1.63%
315,668
-2
-0% -$15
2019 Q1
18 quarters
XFOR icon
11
X4 Pharmaceuticals
XFOR
$286M
$365K 0.47%
11,167
– –
2019 Q2
17 quarters
ITRM icon
12
DELISTED
Iterum Therapeutics
ITRM
$77.7K 0.1%
97,084
– –
2018 Q2
21 quarters
ARAV
13
DELISTED
Aravive, Inc. Common Stock
ARAV
– –
-946,423
Closed -$1.19M –
DICE icon
14
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
– –
-371,693
Closed -$17.3M –

Similar funds

BAM
Broadcrest Asset Management Winter Park, Florida $44.1M AUM 4.51% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
WCPI
Wynnchurch Capital Partners IV Rosemont, Illinois $44.8M AUM 11.91% 1-Year Est. Return
WAMC
Western Asset Management Company Pasadena, California $45.2M AUM 6.96% 1-Year Est. Return
CC
Corton Capital Carrying Place, Ontario, Canada $40.7M AUM 52.32% 1-Year Est. Return
CIEP
Constellation Investimentos e Participacoes Sao Paulo, Brazil $46.7M AUM 23.3% 1-Year Est. Return
IPI
Inflection Point Investments London, United Kingdom $46.9M AUM 18.35% 1-Year Est. Return
VSAM
Value Star Asset Management Hong Kong $49.2M AUM 60.1% 1-Year Est. Return

New Leaf Venture Partners's Q3 2023 Portfolio in Review

As of Q3 2023, New Leaf Venture Partners held 14 positions worth $77.9M, down 33% from $116M the previous quarter. Its ten largest holdings account for 99% of the portfolio.

New Leaf Venture Partners withdrew a net $18.5M in Q3 2023, closing 2 positions and reducing 1 holding. Its most notable exit was DICE Therapeutics, Inc. Common Stock, an estimated $17.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • New Leaf Venture Partners's biggest Q3 2023 reduction was Harpoon Therapeutics, Inc. Common Stock, cutting an estimated $15.
  • New Leaf Venture Partners fully exited DICE Therapeutics, Inc. Common Stock in Q3 2023, selling an estimated $17.3M.
  • New Leaf Venture Partners's ten largest holdings make up 99% of its $77.9M portfolio in Q3 2023.
  • New Leaf Venture Partners opened 0 new positions and closed 2 in Q3 2023.
  • New Leaf Venture Partners's portfolio value fell 33% quarter-over-quarter to $77.9M.

Based on New Leaf Venture Partners's 13F filing for Q3 2023, filed 14 Nov 2023.